Pulmicort and Injection site oedema - a phase IV clinical study of FDA data

Summary:

Injection site oedema is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 30-39 old, also take Ventolin, and have Acromegaly.

The phase IV clinical study analyzes which people have Injection site oedema when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Injection site oedema?

Injection site oedema is found to be associated with 259 drugs and 342 conditions by eHealthMe. Check the latest studies of Injection site oedema.

On Jul, 05, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 13 people (0.04%) have Injection site oedema.

Could Pulmicort cause Injection site oedema?

Among these 13 people:

What is the gender of people who have Injection site oedema when taking Pulmicort? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Injection site oedema when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Injection site oedema? *

Injection Site Pain: 8 people, 61.54%
Injection Site Erythema (redness at injection site): 6 people, 46.15%
Injection Site Pruritus (severe itching at injection site): 5 people, 38.46%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 5 people, 38.46%
Injection Site Swelling: 5 people, 38.46%
Eye Swelling: 5 people, 38.46%
Hypersensitivity: 5 people, 38.46%
Headache (pain in head): 5 people, 38.46%
Back Pain: 4 people, 30.77%
Drug Ineffective: 4 people, 30.77%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 3 people, 23.08%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 15.38%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 15.38%
Vitamin B12 Decreased: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Respiratory Disorder (respiratory disease): 1 person, 7.69%
Primary Immunodeficiency Syndrome: 1 person, 7.69%
Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
Neuralgia (pain in one or more nerves): 1 person, 7.69%
Muscle Aches (muscle pain): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Injection site oedema?

- Check whether Injection site oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site oedema:

Injection site oedema (259 drugs)

Browse all the conditions that are associated with Injection site oedema:

Injection site oedema (342 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.